Pembroke Management LTD Decreases Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Pembroke Management LTD trimmed its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 1.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 305,219 shares of the company’s stock after selling 4,295 shares during the period. Ryan Specialty accounts for about 2.5% of Pembroke Management LTD’s holdings, making the stock its 16th largest holding. Pembroke Management LTD owned about 0.12% of Ryan Specialty worth $19,583,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in RYAN. Hollencrest Capital Management acquired a new position in shares of Ryan Specialty during the 3rd quarter worth $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty during the third quarter worth about $34,000. Principal Securities Inc. boosted its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock worth $43,000 after purchasing an additional 415 shares during the period. Quarry LP grew its position in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after acquiring an additional 422 shares in the last quarter. Finally, Signaturefd LLC lifted its stake in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after acquiring an additional 148 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $67.39, for a total value of $2,358,650.00. Following the completion of the transaction, the director now owns 65,100 shares in the company, valued at approximately $4,387,089. This represents a 34.97 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 323,506 shares of company stock worth $21,407,851. Insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Up 0.2 %

Ryan Specialty stock opened at $68.75 on Tuesday. The stock has a market capitalization of $18.00 billion, a price-to-earnings ratio of 89.29, a PEG ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 1-year low of $44.84 and a 1-year high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The business has a fifty day moving average price of $65.53 and a 200-day moving average price of $67.23.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Morgan Stanley started coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods decreased their price target on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. Finally, Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of “Hold” and a consensus price target of $74.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.